The safety of indacaterol for the treatment of COPD-Reference-Cited by-同舟云学术

The safety of indacaterol for the treatment of COPD

Published:2018-05-09 Issue:6 Volume:17 Page:637-642
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Metaxas Evgenios I.¹²,Balis Evangelos¹

Affiliation:

1. Department of Pulmonary Medicine, Evaggelismos General Hospital, Athens, Greece

2. Department of Pulmonary Medicine, Polyclinic Ygia Hospital, Limassol, Cyprus

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2018.1472233

Reference58 articles.

1. GOLD. 2017. Global Strategy for the Diagnosis, Management and Prevention of COPD. [cited 2018 Feb 10]. Available from: http://goldcopd.org/download/326/

2. Compliance with US asthma management guidelines and specialty care: a regional variation or national concern?

3. In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action

4. The long-acting β-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells

5. Efficacy, Safety and Pharmacokinetics of Indacaterol in Caucasian and Japanese Patients with Chronic Obstructive Pulmonary Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A Combination Therapy for Asthma;Current Respiratory Medicine Reviews;2022-05

2. Prediction of pharmacokinetic parameters of inhaled indacaterol formulation in healthy volunteers using physiologically-based pharmacokinetic (PBPK) model;European Journal of Pharmaceutical Sciences;2022-01

3. Real-world Safety and Efficacy of Indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan;Internal Medicine;2021-08-01

4. Role of β2-adrenergic receptors in chronic obstructive pulmonary disease;Life Sciences;2021-01

Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease

;Journal of Experimental Pharmacology;2020-12